BIOMARKER-BASED BAYESIAN ADAPTIVE DESIGNS FOR TARGETED AGENT DEVELOPMENT

被引：0
|
作者：
Lee, J. J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Bayesian adaptive designs; Biomarkers; outcome-based adaptive randomization; interim analysis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S91 / S92
页数：2
相关论文
共 50 条
  • [31] Biomarker-Based Methods and Study Designs to Calibrate Dietary Intake for Assessing Diet-Disease Associations
    Huang, Ying
    Zheng, Cheng
    Tinker, Lesley F.
    Neuhouser, Marian L.
    Prentice, Ross L.
    JOURNAL OF NUTRITION, 2022, 152 (03): : 899 - 906
  • [32] Progress and prospects of biomarker-based targeted therapy and immune checkpoint inhibitors in advanced gastric cancer
    Zeng, Zhu
    Zhu, Qing
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [33] DEVELOPMENT AND VALIDATION OF A BIOMARKER-BASED CARDIOVASCULAR RISK PREDICTION SCORE IN RHEUMATOID ARTHRITIS
    Curtis, J.
    Xie, F.
    Crowson, C. S.
    Mabey, B.
    Flake, D.
    Bamford, R.
    Chin, C.
    Sasso, E.
    Hitraya, E.
    Ben-Shachar, R.
    Gutin, A.
    Lanchbury, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 874 - 875
  • [34] Development of a Novel Biomarker-based Risk Score for Heart Failure in Patients With Diabetes
    Berg, David D.
    Wiviott, Stephen D.
    Scirica, Benjamin M.
    Goodrich, Erica
    Bhatt, Deepak L.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Wilding, John
    Johanson, Per
    Langkilde, Anna Maria
    Braunwald, Eugene
    Sabatine, Marc S.
    Morrow, David A.
    CIRCULATION, 2020, 142
  • [35] Biomarker adaptive designs in clinical trials
    Chen, James J.
    Lu, Tzu-Pin
    Chen, Dung-Tsa
    Wang, Sue-Jane
    TRANSLATIONAL CANCER RESEARCH, 2014, 3 (03) : 279 - 292
  • [36] Bayesian adaptive designs for clinical trials
    Cheng, Y
    Shen, Y
    BIOMETRIKA, 2005, 92 (03) : 633 - 646
  • [37] Testing dilemmas in the clinic: Lessons learned from biomarker-based drug development
    van Waalwijk van Doorn-Khosrovani, Sahar Barjesteh
    Van Criekingen, Olga Kholmanskikh
    Koole, Simone
    Thomas, David M.
    Gelderblom, Hans
    CANCER CELL, 2024, 42 (06) : 923 - 929
  • [38] Optimal Interim Decision Rules Based on a Binary Surrogate Outcome for Adaptive Biomarker-Based Trials in Oncology
    Krisam, Johannes
    Kieser, Meinhard
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2017, 9 (04): : 321 - 332
  • [39] Biomarker-based Bayesian randomized phase II clinical trial design to identify a sensitive patient subpopulation
    Morita, Satoshi
    Yamamoto, Hideharu
    Sugitani, Yasuo
    STATISTICS IN MEDICINE, 2014, 33 (23) : 4008 - 4016
  • [40] Biomarker-based risk scores in atrial fibrillation
    Hijazi, Ziad
    Mills, Nicholas L.
    Mueller, Christian
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2021, 10 (09) : 1084 - 1085
12345